[go: up one dir, main page]

ITMI930699A0 - Nuovi derivati dell'indolo - Google Patents

Nuovi derivati dell'indolo

Info

Publication number
ITMI930699A0
ITMI930699A0 ITMI930699A ITMI930699A ITMI930699A0 IT MI930699 A0 ITMI930699 A0 IT MI930699A0 IT MI930699 A ITMI930699 A IT MI930699A IT MI930699 A ITMI930699 A IT MI930699A IT MI930699 A0 ITMI930699 A0 IT MI930699A0
Authority
IT
Italy
Prior art keywords
indile
derivatives
new
new indile
indile derivatives
Prior art date
Application number
ITMI930699A
Other languages
English (en)
Inventor
Vincenzo Martino
Marco Turconi
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of ITMI930699A0 publication Critical patent/ITMI930699A0/it
Priority to ITMI930699A priority Critical patent/IT1271352B/it
Priority to AU65382/94A priority patent/AU684276B2/en
Priority to HU9502913A priority patent/HUT74090A/hu
Priority to NZ265055A priority patent/NZ265055A/en
Priority to SG1996002949A priority patent/SG50507A1/en
Priority to CA002160020A priority patent/CA2160020A1/en
Priority to FI954734A priority patent/FI954734L/fi
Priority to PCT/EP1994/001016 priority patent/WO1994024125A1/en
Priority to US08/530,354 priority patent/US5834493A/en
Priority to BR9406206A priority patent/BR9406206A/pt
Priority to PL94310995A priority patent/PL310995A1/xx
Priority to JP6522684A priority patent/JPH08508738A/ja
Priority to SK1197-95A priority patent/SK119795A3/sk
Priority to EP94913101A priority patent/EP0694033A1/en
Priority to CZ952602A priority patent/CZ283398B6/cs
Priority to CN94192345A priority patent/CN1124960A/zh
Priority to IL109234A priority patent/IL109234A/en
Priority to ZA942383A priority patent/ZA942383B/xx
Publication of ITMI930699A1 publication Critical patent/ITMI930699A1/it
Priority to BG100040A priority patent/BG100040A/bg
Priority to NO953967A priority patent/NO953967L/no
Application granted granted Critical
Publication of IT1271352B publication Critical patent/IT1271352B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
ITMI930699A 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale IT1271352B (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
PL94310995A PL310995A1 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
SK1197-95A SK119795A3 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
NZ265055A NZ265055A (en) 1993-04-08 1994-03-31 3-(tetra(or hexa)hydro-pyridin-3-yl-methyl)-1h-indole derivatives, compounds, preparative process and medicaments
SG1996002949A SG50507A1 (en) 1993-04-08 1994-03-31 Indole derivates as 5-ht1a and/or 5-ht2 ligands
CA002160020A CA2160020A1 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
FI954734A FI954734L (fi) 1993-04-08 1994-03-31 Indolijohdannaiset 5HT1A ja/tai 5-HT2 ligandeina
PCT/EP1994/001016 WO1994024125A1 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
US08/530,354 US5834493A (en) 1993-04-08 1994-03-31 Indole derivatives as 5-HT1A and/or 5-HT2 ligands
BR9406206A BR9406206A (pt) 1993-04-08 1994-03-31 Derivados de indol como ligantes 5-ht1a e/ou 5-ht2
AU65382/94A AU684276B2 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-HT1A and/or 5-HT2 ligands
JP6522684A JPH08508738A (ja) 1993-04-08 1994-03-31 ５−ｈｔ１ａ及び／又は５−ｈｔ２リガンドとしてのインドール誘導体
HU9502913A HUT74090A (en) 1993-04-08 1994-03-31 Indole derivatives, process for producing them and pharmaceutical compositions containing them
EP94913101A EP0694033A1 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
CZ952602A CZ283398B6 (cs) 1993-04-08 1994-03-31 Indolové deriváty jako 5-HT1A a/nebo 5-HT2 ligandy
CN94192345A CN1124960A (zh) 1993-04-08 1994-03-31 作为5-ht/a和/或5-ht2配体的吲哚衍生物
IL109234A IL109234A (en) 1993-04-08 1994-04-06 Indole derivatives, their preparation and pharmaceutical compositions containing them
ZA942383A ZA942383B (en) 1993-04-08 1994-04-07 New indole derivatives
BG100040A BG100040A (bg) 1993-04-08 1995-10-02 Индолови производни като 5-нт1а и/или 5-нт2 лиганди
NO953967A NO953967L (no) 1993-04-08 1995-10-05 Indolderivater som 5-HT1A og/eller 5-HT2 ligander

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale

Publications (3)

Publication Number Publication Date
ITMI930699A0 true ITMI930699A0 (it) 1993-04-08
ITMI930699A1 ITMI930699A1 (it) 1994-10-08
IT1271352B IT1271352B (it) 1997-05-27

Family

ID=11365694

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale

Country Status (20)

Country Link
US (1) US5834493A (it)
EP (1) EP0694033A1 (it)
JP (1) JPH08508738A (it)
CN (1) CN1124960A (it)
AU (1) AU684276B2 (it)
BG (1) BG100040A (it)
BR (1) BR9406206A (it)
CA (1) CA2160020A1 (it)
CZ (1) CZ283398B6 (it)
FI (1) FI954734L (it)
HU (1) HUT74090A (it)
IL (1) IL109234A (it)
IT (1) IT1271352B (it)
NO (1) NO953967L (it)
NZ (1) NZ265055A (it)
PL (1) PL310995A1 (it)
SG (1) SG50507A1 (it)
SK (1) SK119795A3 (it)
WO (1) WO1994024125A1 (it)
ZA (1) ZA942383B (it)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
TR199902759T2 (xx) * 1997-05-09 2000-01-21 H. Lundbeck A/S Sertindole �retimi i�in bir y�ntem
ATE271555T1 (de) 1998-01-14 2004-08-15 Uab Research Foundation Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
US6133287A (en) * 1998-03-24 2000-10-17 Allelix Biopharmaceuticals Inc. Piperidine-indole compounds having 5-HT6 affinity
CA2327303A1 (en) * 1998-04-08 1999-10-14 American Home Products Corporation N-aryloxyethylamine derivatives for the treatment of depression
JP2002513018A (ja) * 1998-04-29 2002-05-08 アメリカン・ホーム・プロダクツ・コーポレイション セロトニン作動薬
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
DE19951360A1 (de) * 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
JP2004520325A (ja) * 2000-12-22 2004-07-08 ワイス ５−ヒドロキシトリプトアミン−６−リガンドとしてのヘテロシクリルアルキルインドールまたは−アザインドール化合物
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
JP5894574B2 (ja) * 2010-04-22 2016-03-30 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
WO2013155505A1 (en) 2012-04-14 2013-10-17 Intra-Cellular Therapies, Inc Organic compounds
US9708322B2 (en) 2013-03-15 2017-07-18 Intra-Cellular Therapies, Inc. Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
KR102373288B1 (ko) 2013-12-03 2022-03-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
AU2015240526A1 (en) 2014-04-04 2016-11-24 Intra-Cellular Therapies, Inc. Organic compounds
JP2017509686A (ja) 2014-04-04 2017-04-06 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
WO2017023894A1 (en) * 2015-08-03 2017-02-09 Raze Therapeutics, Inc. Mthfd2 inhibitors and uses thereof
MX385678B (es) 2016-01-26 2025-03-18 Intra Cellular Therapies Inc Gamma-carbolinas heterocíclicas fusionadas sustituidas, composiciones farmacéuticas y métodos de uso.
IL297676B2 (en) 2016-03-25 2023-12-01 Intra Cellular Therapies Inc A controlled or delayed release pharmaceutical preparation containing a deuterated compound
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
EP3525763B1 (en) 2016-10-12 2025-03-05 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
US10906906B2 (en) 2016-12-29 2021-02-02 Intra-Cellular Therapies, Inc. Organic compounds
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
IL304026B2 (en) 2017-03-24 2024-11-01 Intra Cellular Therapies Inc A pharmaceutical preparation containing 1-(4-fluoro-phenyl)-4-((Sa10,Rb6)-3-D2-2,2-methyl-2, 3, a10, 10, 9, b6- hexahydro-H7, H1- Pyrido[3',4',:4,5]pyrrolo[3,2,1-de]quioxalin-8-yl)-butan-1-one and its uses
JP7223742B2 (ja) 2017-07-26 2023-02-16 イントラ－セルラー・セラピーズ・インコーポレイテッド 有機化合物
MX2020000967A (es) 2017-07-26 2020-09-28 Intra Cellular Therapies Inc Compuestos organicos.
JP7462568B2 (ja) 2018-03-23 2024-04-05 イントラ－セルラー・セラピーズ・インコーポレイテッド 有機化合物
EP3801527B1 (en) 2018-06-08 2025-02-19 Intra-Cellular Therapies, Inc. Fused gamma-carbolines for acute treatment of anxiety or depression
WO2020047241A1 (en) 2018-08-29 2020-03-05 Intra-Cellular Therapies, Inc. Novel compositions and methods
CN118873536A (zh) 2018-08-31 2024-11-01 细胞内治疗公司 新方法
BR112021003655A2 (pt) 2018-08-31 2021-05-18 Intra-Cellular Therapies, Inc. métodos novos
BR112022000231A2 (pt) 2019-07-07 2022-02-22 Intra Cellular Therapies Inc Novos métodos
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
ES2104733T3 (es) * 1990-10-15 1997-10-16 Pfizer Derivados de indol.
JP3140155B2 (ja) * 1992-03-09 2001-03-05 杏林製薬株式会社 Ｎ，ｎ’−ジ置換アミド誘導体
TW226019B (it) * 1992-03-23 1994-07-01 Sankyo Co

Also Published As

Publication number Publication date
AU6538294A (en) 1994-11-08
SK119795A3 (en) 1996-04-03
NZ265055A (en) 1996-09-25
FI954734A7 (fi) 1995-10-05
CZ283398B6 (cs) 1998-04-15
ZA942383B (en) 1995-10-09
EP0694033A1 (en) 1996-01-31
CA2160020A1 (en) 1994-10-27
AU684276B2 (en) 1997-12-11
PL310995A1 (en) 1996-01-22
SG50507A1 (en) 1998-07-20
NO953967D0 (no) 1995-10-05
HUT74090A (en) 1996-11-28
CZ260295A3 (en) 1996-01-17
IT1271352B (it) 1997-05-27
FI954734A0 (fi) 1995-10-05
JPH08508738A (ja) 1996-09-17
IL109234A0 (en) 1994-07-31
WO1994024125A1 (en) 1994-10-27
NO953967L (no) 1995-12-05
HU9502913D0 (en) 1995-11-28
BG100040A (bg) 1996-03-29
BR9406206A (pt) 1996-02-06
CN1124960A (zh) 1996-06-19
IL109234A (en) 1998-04-05
US5834493A (en) 1998-11-10
ITMI930699A1 (it) 1994-10-08
FI954734L (fi) 1995-10-05

Similar Documents

Publication Publication Date Title
ITMI930699A0 (it) Nuovi derivati dell'indolo
FI932229A7 (fi) Atsabisyklisiä siltajohdannaisia
FI930208L (fi) Kinazolinderivat
ATA75293A (de) Indolderivate
FI943976A7 (fi) 5-aryyli-indolijohdannaiset
FI933037A7 (fi) Tiazolylvinylfenylderivat
DE69330497D1 (de) Chinazolin-derivate
FI945674A7 (fi) Substituoidut 2beta-morfoliini-androstaanijohdannaiset
FI20010214L (fi) Asyyliaminoindolijohdannaisia
FI942444A7 (fi) Terahydropyraanijohdannaisia
FI943885L (fi) Penaami-johdannaiset
DE59308714D1 (de) Cyclobutan-benzol-derivate
FI20002460A7 (fi) 4-difenyylimetyylipiperidiinijohdannaisia
FI944044L (fi) Fenyylialkanoliamiinijohdannaiset
FI932928A7 (fi) Uudet bentsodiatsepiinijohdokset
IT1243300B (it) Derivati dell'eparina
FI953784A7 (fi) 3'-atsiridinoantrasykliinijohdannaiset
DE69313890D1 (de) 5-Aminoflavon-Derivate
ITMI941191A0 (it) 1-b-metil-2-tiol carbapen derivati
DE59407726D1 (de) 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
FI931794L (fi) Monokvaternaera 2,16-bispiperidinylandrostanderivat
FI930934L (fi) Tetrahydropyrimidinderivat
FI930873A7 (fi) Tetrahydrotiofenderivat
FI930922A7 (fi) Substituerade fenylkinazolinderivat
FI931425L (fi) Aminosockerderivat

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970329